Recruiting Heart Attack Studies in Perth
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
This is a Phase Ib/II, open-label, multi-center study evaluating the safety, tolerability, efficacy and PK of APG-2575 in combination with Azacitidine in the patients with AML/MPAL or MDS/CMML. The st...
About Heart Attack Clinical Trials in Perth
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Perth, WASHINGTON. These studies are seeking a combined 122 participants. Research is being sponsored by Amgen, Ascentage Pharma Group Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Perth — FAQ
Are there heart attack clinical trials in Perth?
Yes, there are 2 heart attack clinical trials currently recruiting in Perth, WASHINGTON. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Perth?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Perth research site will contact you about next steps.
Are clinical trials in Perth free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Perth studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Perth are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov